Orally active, nonpeptide vitronectin receptor (αvβ3) antagonists.

被引：0

作者：

Miller, WH ^{[1
]}

机构：

[1] SmithKline Beecham Pharmaceut, Dept Med Chem, King Of Prussia, PA 19406 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1998年 / 215卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

002-MEDI

引用

页码：U861 / U861

页数：1

共 50 条

[1] Discovery of orally active vitronectin receptor (αvβ3) antagonists.
Heerding, DA
Miller, WH
Willette, R
Yue, TL
Lark, M
Stroup, G
Badger, A
Ohlstein, E
Gowen, M
Huffman, WF
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U567 - U568
[2] Orally active, nonpeptide vitronectin receptor (αvβ3) antagonists in angiogenesis.
Samanen, JM
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 215 : U920 - U921
[3] Potent, selective, orally active, nonpeptide vasopressin receptor antagonists.
Matthews, JM
Dyatkin, AB
Hecker, L
Hlasta, DJ
Hoekstra, WJ
Poulter, B
Andrade-Gordon, P
de Garavilla, L
Demarest, K
Ericson, E
Gunnet, J
Hagman, W
Look, R
Moore, J
Reynolds, CH
Maryanoff, BE
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U913 - U914
[4] Orally bioavailable nonpeptide vitronectin receptor antagonists with efficacy in an osteoporosis model
Miller, WH
Bondinell, WE
Cousins, RD
Erhard, KF
Jakas, DR
Keenan, RM
Ku, TW
Newlander, KA
Ross, ST
Haltiwanger, RC
Bradbeer, J
Drake, FH
Gowen, M
Hoffman, SJ
Hwang, SM
James, IE
Lark, MW
Lechowska, B
Rieman, DJ
Stroup, GB
Vasko-Moser, JA
Zembryki, DL
Azzarano, LM
Adams, PC
Salyers, KL
Smith, BR
Ward, KW
Johanson, KO
Huffman, WF
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (13) : 1807 - 1812
[5] Nonpeptide vitronectin receptor antagonists
Miller, W
Keenan, R
Ali, F
Bondinell, W
Burgess, J
Callahan, J
Calvo, R
Cousins, R
Gowen, M
Huffman, W
Hwang, S
Jakas, D
Ku, T
Kwon, C
Lago, A
Nguyen, T
Reader, V
Ross, S
Samanen, J
Southall, L
Takata, D
Uzinskas, I
Venslavsky, J
Wong, A
Yellin, T
Yuan, C
[J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 : M429 - M429
[6] Nonpeptide vitronectin receptor antagonists
Keenan, R
Miller, W
Ali, F
Barton, L
Bondinell, B
Burgess, J
Callahan, J
Calvo, R
Cousins, R
Gowen, M
Huffman, W
Hwang, S
Jakas, D
Ku, T
Kwon, C
Lago, A
Mombouyran, V
Nguyen, T
Ross, S
Samanen, J
Takata, D
Uzinskas, I
Venslavsky, J
Wong, A
Yellin, T
Yuan, C
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 211 : 236 - MEDI
[7] Discovery of potent nonpeptide vitronectin receptor (alpha(v)beta(3)) antagonists
Keenan, RM
Miller, WH
Kwon, C
Ali, FE
Callahan, JF
Calvo, RR
Hwang, SM
Kopple, KD
Peishoff, CE
Samanen, JM
Wong, AS
Yuan, CK
Huffman, WF
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (15) : 2289 - 2292
[8] Synthesis of potent, nonpeptide integrin αvβ3 antagonists.
Ishikawa, M
Yamamoto, M
Kubota, D
Yahata, N
Kuroda, C
Yasuda, S
Fujishima, K
Hachisu, M
Katano, K
Murakami, S
Ajito, K
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 218 : U931 - U932
[9] Synthesis and characterization of orally active nonpeptide vasopressin V2 receptor antagonists
Ohkawa, T
Zenkoh, T
Tomita, M
Hosogai, N
Hemmi, K
Tanaka, H
Setoi, H
[J]. CHEMICAL & PHARMACEUTICAL BULLETIN, 1999, 47 (04) : 501 - 510
[10] Phenylbutyrates as potent, orally bioavailable vitronectin receptor (integrin αvβ3) antagonists
Miller, WH
Manley, PJ
Cousins, RD
Erhard, KF
Heerding, DA
Kwon, C
Ross, ST
Samanen, JM
Takata, DT
Uzinskas, IN
Yuan, CCK
Haltiwanger, RC
Gress, CJ
Lark, MW
Hwang, SM
James, IE
Rieman, DJ
Willette, RN
Yue, TL
Azzarano, LM
Salyers, KL
Smith, BR
Ward, KW
Johanson, KO
Huffman, WF
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (08) : 1483 - 1486

← 1 2 3 4 5 →